RDD Pharma Appoints Dr. Mark Sirgo as Board Chairman

NEW YORK, June 4, 2018 -- (Healthcare Sales & Marketing Network) -- RDD Pharma, a specialty pharma company focused on innovative therapies for anorectal diseases and gastrointestinal disorders, today announced the appointment of Dr. Mark Sirgo as the Chai... Biopharmaceuticals, Gatroenterology, Personnel RDD Pharma, anal fissure, fecal incontinence, colitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news